Nathalie Horowicz-Mehler
Global Vice President, Head of HEOR and Evidence
Nathalie brings more than 25 years of experience in health economics and real-world evidence to Cytel’s Evidence, Value and Access business. She has a proven track record of driving growth by leading teams of scientist entrepreneurs and applies her clinical expertise as an epidemiologist and experience with HEOR, RWE/RWD and advanced analytics to catalyze innovations in public health.
Nathalie has held leadership roles at IQVIA, Concert AI, and Exponent. As Senior Vice President GM at ConcertAI, she leveraged her expertise to successfully establish their health economics and epidemiology practice. Most recently, she served as Principal Scientist at Exponent, focusing on pharmaceutical sector advancements and healthcare innovation.
Nathalie has an MS from Tufts University School of Medicine, and both an MPH and PhD from Columbia University Mailman School of Public Health.
Related Articles
Panel Discussion – One Pivotal Trial Plus Confirmatory Evidence: Understanding FDA’s New Framework
White Paper – The FDA’s Shift to One Pivotal Trial Plus Confirmatory Evidence: A New Era of Evidence for Drug Development
Leveraging RWE Innovations to Inform Clinical Strategy and Strengthen Healthcare Decision-Making
Generative AI in Evidence Synthesis: Harnessing Potential with Responsibility
